Although the name has been tweaked over the years, and the principal investigator has changed, the Summer Institute on Innovative Methods workshop series has been held annually since 1996. Originally created by Linda M. Collins, and hosted by The Methodology Center at Penn State, this annual workshop series is ongoing and is now led by Bethany C. Bray and the Institute for Health Research and Policy at The University of Illinois at Chicago. This workshop series is funded, in part, by an award from the National Institute on Drug Abuse (R13 DA020334). Information about this year’s workshop and historical information about past workshops is available below.
2020-2021 Summer Institute on Innovative Methods:
Building Effective Just-in-Time Adaptive Interventions Using Micro-Randomized Trial Designs
Susan Murphy & Daniel Almirall
The 2020 Summer Institute has been postponed until October 25-26, 2021 due to COVID-19.
A just-in-time adaptive intervention (JITAI) is an emerging mobile health intervention design aiming to provide support “just-in-time”, namely, whenever and wherever support is needed. A JITAI does this via adaptation. The JITAI employs wearable sensors and other approaches to data collection to monitor ongoing information on the dynamics of an individual’s emotional, social, physical and contextual states. The adaptation occurs when this information is used to individualize the type and delivery timing of support. The adaptation in a JITAI is intended to ensure that the right type of support is provided whenever the person is (a) vulnerable and/or is in a state of opportunity, and (b) receptive, namely, able and willing to receive, process and utilize the support provided.
past summer institutes
- 2020 – Building Effective Just-in-Time Adaptive Interventions Using Micro-Randomized Trial Designs (Susan Murphy & Daniel Almirall)
- 2019 – Variability in Intensive Longitudinal Data: Mixed-Effects Location Scale Modeling (Donald Hedeker)
- 2018 – Analysis of Ecological Momentary Assessment Data (Stephanie Lanza & Michael Russell)
- 2017 – Statistical Power Analysis for Intensive Longitudinal Studies (Jean-Philippe Laurenceau & Niall Bolger)
- 2016 – Ecological Momentary Assessment (EMA): Investigating Biopsychosocial Processes in Context (Joshua Smyth, Kristin Heron, & Michael Russell)
- 2015 – An Introduction to Time-Varying Effect Modeling (Stephanie Lanza & Sara Vasilenko)
- 2014 – Experimental Design and Analysis Methods for Developing Adaptive Interventions: Getting SMART (Daniel Almirall & Inbal Nahum-Shani)
- 2013 – Introduction to Latent Class Analysis (Stephanie Lanza & Bethany Bray)
- 2012 – Causal Inference (Donna Coffman)
- 2011 – The Multiphase Optimization Strategy (Linda Collins)
- 2010 – Analysis of Longitudinal Dyadic Data (Niall Bolger & Jean-Philippe Laurenceau)
- 2009 – Latent Class and Latent Transition Analysis (Linda Collins & Stephanie Lanza)
- 2008 – Statistical Mediation Analysis (David MacKinnon)
- 2007 – Mixed Models & Practical Tools for Causal Inference (Donald Hedeker & Joseph Schafer)
- 2006 – Causal Inference (Christopher Winship & Felix Elwert)
- 2005 – Survival Analysis (Paul Allison)
- 2004 – Analyzing Developmental Trajectories (Daniel Nagin)
- 2003 – Modeling Change and Event Occurrence (Judith Singer & John Willett)
- 2002 – Missing Data (Joseph Schafer)
- 2001 – Longitudinal Modeling with Mplus (Bengt Muthén & Linda Muthén)
- 2000 – Integrating Design and Analysis & Mixed-Effect Models (Richard Campbell, Paras Mehta, & Donald Hedeker)
- 1999 – Structural Equation Modeling (John McArdle)
- 1998 – Categorical Data Analysis (David Rindskopf & Linda Collins)
- 1997 – Hierarchical Linear Models & Missing Data Analysis (Stephen Raudenbush & Joseph Schafer)
- 1996 – Analysis of Stage Sequential Development (Linda Collins, Peter Molenaar, & Han van der Maas)
Funding for this conference was provided by award number R13 DA020334 from the National Institute on Drug Abuse. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official views and/or policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.